Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2018-09-25 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FONTENAY-AUX-ROSES (92260), Hauts-de-Seine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
GRANDE PHARMACIE DE FONTENAY AUX ROSES : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DE FONTENAY AUX ROSES is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FONTENAY-AUX-ROSES (92260),
this company of category PME
shows in 2022 a net income positive of 338 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DE FONTENAY AUX ROSES (SIREN 842576548)
Indicator
2022
2021
2019
Revenue
N/C
N/C
N/C
Net income
338 410 €
349 134 €
65 428 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2022, GRANDE PHARMACIE DE FONTENAY AUX ROSES generates positive net income of 338 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2022: 65 k€ -> 338 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
338 410 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 168%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
168.096%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
32.372%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DE FONTENAY AUX ROSES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2021
2022
Debt ratio
1390.653
272.241
168.096
Financial autonomy
6.029
22.999
32.372
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
168.12022
2019
2021
2022
Q1: 24.5
Med: 74.73
Q3: 182.59
Average
In 2022, the debt ratio of GRANDE PHARMACIE DE FONTE... (168.10) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
32.37%2022
2019
2021
2022
Q1: 28.53%
Med: 47.06%
Q3: 66.62%
Average+5 pts over 3 years
In 2022, the financial autonomy of GRANDE PHARMACIE DE FONTE... (32.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 228.42. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
228.418
Liquidity indicators evolution GRANDE PHARMACIE DE FONTENAY AUX ROSES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2021
2022
Liquidity ratio
182.795
197.627
228.418
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
228.422022
2019
2021
2022
Q1: 145.2
Med: 199.49
Q3: 275.01
Good
In 2022, the liquidity ratio of GRANDE PHARMACIE DE FONTE... (228.42) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of GRANDE PHARMACIE DE FONTENAY AUX ROSES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of GRANDE PHARMACIE DE FONTENAY AUX ROSES is estimated at
3 981 904 €
(range 2 676 630€ - 5 972 116€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
2676k€3981k€5972k€
3 981 904 €Range: 2 676 630€ - 5 972 116€
NAF 5 année 2022
Valuation method used
Net Income Multiple
338 410 €
×
11.8x
=3 981 904 €
Range: 2 676 631€ - 5 972 117€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DE FONTENAY AUX ROSES with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DE FONTENAY AUX ROSES
What is the revenue of GRANDE PHARMACIE DE FONTENAY AUX ROSES ?
The revenue of GRANDE PHARMACIE DE FONTENAY AUX ROSES is not publicly disclosed (confidential accounts filed with INPI).
Is GRANDE PHARMACIE DE FONTENAY AUX ROSES profitable?
Yes, GRANDE PHARMACIE DE FONTENAY AUX ROSES generated a net profit of 338 k€ in 2022.
Where is the headquarters of GRANDE PHARMACIE DE FONTENAY AUX ROSES ?
The headquarters of GRANDE PHARMACIE DE FONTENAY AUX ROSES is located in FONTENAY-AUX-ROSES (92260), in the department Hauts-de-Seine.
Where to find the tax return of GRANDE PHARMACIE DE FONTENAY AUX ROSES ?
The tax return of GRANDE PHARMACIE DE FONTENAY AUX ROSES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DE FONTENAY AUX ROSES operate?
GRANDE PHARMACIE DE FONTENAY AUX ROSES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart